Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the cannabis pharmaceuticals market?
The market for pharmaceutical cannabis has seen substantial expansion in the latest years. Its projected growth is from $6.03 billion in 2024 to a whopping $9.45 billion in 2025, suggesting a compound annual growth rate (CAGR) of 56.66%. Causes for this uptick during the historic period include the increased legal sanctioning of medicinal cannabis, burgeoning awareness of the beneficial effects of cannabinoid therapy, a rise in the occurrence of chronic and neurological diseases, conducive regulatory structures, increased investment in pharmaceuticals, and a change in the public’s perception of the use of cannabis in healthcare.
What will be the cannabis pharmaceuticals market size in the future?
The market size for cannabis pharmaceuticals is set to witness significant growth over the upcoming years. By 2029, it is predicted to expand to a value of $56.37 billion, with an impressive compound annual growth rate (CAGR) of 56.29%. This escalation during the projection period can be linked to a rise in regulatory approvals, an increased understanding of the therapeutic benefits of medical cannabis, a broadening range of uses in managing pain and neurological disorders, an escalating number of chronic disease cases, enhancements in drug delivery mechanisms, and the introduction of beneficial reimbursement policies. Future trends will revolve around advancements in technology for extracting cannabinoids, the creation of targeted drug delivery systems, the utilization of synthetic cannabinoid formulations, bettered clinical trial procedures, and the incorporation of artificial intelligence into drug discovery.
Get your cannabis pharmaceuticals market report here!
https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report
What main drivers are fueling expansion in the cannabis pharmaceuticals market?
The upward trend in epilepsy cases is forecasted to propel the cannabis pharmaceuticals market. Epilepsy is defined as a neurological condition characterized by recurring, unprovoked seizures due to abnormal brain electric activity. The growth in epilepsy instances can be credited to improved diagnosis, heightened awareness, and bolstered reporting, in addition to potential environmental, genetic, and lifestyle factors. Cannabis pharmaceuticals have demonstrated capacity to assist in managing epilepsy by leveraging cannabinoids like CBD to decrease the intensity and frequency of seizures in patients unresponsive to conventional anti-epileptic medications. As an example, in April 2022, the Belgium-based non-profit European Brain Council reported that over 600 neurological diseases and nearly 300 psychiatric conditions impact millions worldwide, including 65 million suffering from epilepsy. Furthermore, in July 2024, the Alzheimer Society of Canada, a Canada-based health charity, estimated that by January 1, 2025, about 771,939 Canadians are anticipated to be afflicted with dementia, a number anticipated to increase to nearly one million by 2030. Hence, the escalating incidence of epilepsy is fueling the expansion of the cannabis pharmaceuticals market.
What key areas define the segmentation of the global cannabis pharmaceuticals market?
The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids
2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions
3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations
Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)
3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp
Who are the dominant players expanding their reach in the cannabis pharmaceuticals market?
Major companies operating in the cannabis pharmaceuticals market are Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte’s Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.
How are evolving market trends shaping cannabis pharmaceuticals Strategies?
Major companies operating in the cannabis pharmaceuticals market are focusing on developing innovative products such as advanced medical cannabis formulations to address a range of medical conditions and improve patient outcomes. Advanced medical cannabis formulations refer to specially designed cannabis-based products that are optimized for therapeutic use, incorporating precise doses of cannabinoids like THC and CBD. For instance, in April 2024, Canexis Pharma AG, a Switzerland-based pharmaceutical company, received manufacturing and narcotics licenses from Swissmedic for cannabis pharmaceuticals. These approvals empower the company to produce premium-grade medicinal active ingredients derived from CBD and THC. This development positions Canexis to meet the growing demand for medical cannabis both within Switzerland and globally. By obtaining these licenses, the company demonstrates its compliance with stringent regulatory standards, enhancing its credibility and ability to contribute to the rapidly evolving medical cannabis market.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20723
Which regions are emerging as leaders in the cannabis pharmaceuticals market?
North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cannabis Products Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-products-global-market-report
Cannabis Testing Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-testing-global-market-report
Cannabis Cultivation Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-cultivation-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
